GIM
BRKR icon

Glenmede Investment Management’s Bruker BRKR Stock Holding History

Glenmede Investment Management’s Portfolio BRKR Stock Details BRKR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$403K Buy
12,404
+2,381
+24% +$84.9K ﹤0.01% 1017
2025
Q2 		$413K Buy
+10,023
New +$387K ﹤0.01% 999

Other funds holding BRKR

OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PCA
Pallas Capital Advisors Braintree, Massachusetts $2.66B AUM 22.31% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EDRH
Edmond de Rothschild Holding Chambesy, Switzerland $6.91B AUM 19.7% 1-Year Est. Return
SC
Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return
LCOV
London Company of Virginia Richmond, Virginia $16.2B AUM 17.5% 1-Year Est. Return

Glenmede Investment Management's BRKR Position: Q3 2025 in Review

Glenmede Investment Management increased its Bruker (BRKR) stake by 24% in Q3 2025, buying an estimated $84.9K and bringing the position to 12,404 shares worth $403K. The position accounts for ﹤0.01% of the portfolio, ranked #1017.

Glenmede Investment Management first reported a position in BRKR in Q2 2025 and has held it in 2 quarters since. The position peaked at $413K in Q2 2025. 339 funds tracked by Wall St. Rank hold BRKR as of Q3 2025.

  • Glenmede Investment Management held 12,404 shares of Bruker worth $403K as of Q3 2025.
  • Glenmede Investment Management bought 2,381 Bruker shares in Q3 2025, an estimated $84.9K.
  • Bruker made up ﹤0.01% of Glenmede Investment Management's portfolio in Q3 2025, its #1017 holding.
  • Glenmede Investment Management first reported a position in Bruker in Q2 2025 and has held it in 2 quarters since.
  • Glenmede Investment Management's Bruker position peaked at $413K in Q2 2025.
  • 339 funds tracked by Wall St. Rank held Bruker as of Q3 2025.

Based on Glenmede Investment Management's 13F filing for Q3 2025, filed 13 Nov 2025.